Navigation Links
Georgetown leads major effort to combat disparities in DC stroke care
Date:10/24/2007

Washington, D.C.More than three quarters of adults living in the District of Columbia have at least one risk factor for stroke, but those who are poor do not receive the same level of care as their wealthier counterparts. In an effort to address these disparities in stroke prevention, diagnosis and treatment in D.C., the NIH's National Institute of Neurological Disorders and Stroke (NINDS) has awarded Georgetown University Medical Center a $10 million cooperative research grant. Chelsea Kidwell, MD, associate professor of neurology at Georgetown, is the principal investigator for the grant, which will involve physicians and scientists from twenty other institutions, including GUMCs clinical partner, Georgetown University Hospital, owned by MedStar Health.

We know that the type of stroke care people get in the United States depends at least in part on their race and socioeconomic status, said Kidwell, who directs both the Georgetown Stroke Center and the Washington Hospital Center Stroke Center. What better place to attempt to reduce these disparities than in the nations capital, where so many patients are coming from medically underserved communities"

Kidwell will oversee three research projects addressing key areas of disparities in stroke care in Washington, D.C. hospitals:

  • Project ASPIRE (Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities) will investigate whether a multi-level intervention can significantly increase the number of ischemic stroke patients appropriately treated with intravenous tissue plasminogen activator (tPA) (clot-busting medication) in D.C. hospitals. If administered within a certain time window, tPA is highly effective at dissolving the blood clots that cause strokes and improving clinical outcomes, said Kidwell, but it is typically delivered to less than 3 percent of patients. Kidwell wants to study the barriers to utilizing this treatment in District hospitals. Amie Hsia, assistant professor of neurology at Georgetown, is the principal investigator on this project.

  • Project PROTECT DC (Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia) will examine whether patient navigatorscommunity health workers paired with stroke patientscan help patients adhere to at-home regimens aimed at preventing a second stroke. The patient navigator model has worked well in cancer, but has never been tested in stroke, said Kidwell. If we can help these patients increase compliance with their medications and other preventive behaviors, we can have a significant public health impact in preventing recurrent strokes. Alexander Dromerick, professor of medicine at Georgetown, is the principal investigator on this project.

  • Project DECIPHER (Differences in the Imaging of Primary Hemorrhage based on Ethnicity or Race) DECIPHER addresses the finding that African Americans (who make up about 60 percent of D.C.s population) are more likely to have chronic brain microbleeds (small regions of asymptomatic bleeding in the brain), which can be a marker for risk of more serious cerebral hemorrhaging. Some MRI studies have shown that African Americans are more likely to have these tiny microbleeds in their brain, even if they have no symptoms, explained Kidwell. We may learn that these microbleeds could be an important marker of brain hemorrhages and possibly predictors of long-term survival. This research will give us new insight into prevention and treatment of intracerebral hemorrhage in this population.

"We are extremely excited about this multi-level, city-wide, acute and secondary stroke intervention program, said Richard T. Benson, MD, PhD, of the NINDS Office of Minority Health and Research. It is one of the first NINDS-funded studies to address stroke disparities using community-based patient management, state of the art imaging, and the identification of novel risk factors."

The researchers expect to begin enrolling patients into each project by the end of 2007. Study sites include Georgetown University Hospital, Howard University Hospital, George Washington University Hospital, Greater Southeast Community Hospital, Washington Hospital Center, Providence Hospital, Sibley Memorial Hospital, National Rehabilitation Hospital, Suburban Hospital, Franklin Square Hospital, Union Memorial Hospital, , Johns Hopkins Bayview Medical Center, and Good Samaritan Hospital. Other collaboratoring investigators are located at Medstar Research Institute, University of Wisconsin, Johns Hopkins University, UCLA and the University of Michigan.


'/>"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Georgetown University Heads Alternative Tobacco Project
2. Drinking arsenic water leads to cancer
3. Doctor Pleads Not Guilty
4. Coronary stent leads to complications
5. Starving leads to obesity
6. Drug abuse leads to long standing changes in the brain
7. Deprived sleep leads to ageing
8. Tobacco chewing leads to dental caries
9. Tongue piercing leads to bacterial infection
10. Cathine leads to mental health disorder
11. Space research leads to needle-free blood tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Splashtop Inc., the worldwide leader in high performance ... the leading provider of secure mobile remote access solution for Japan enterprises. ... remote access solution. Splashtop for CACHATTO will be available as an integrated ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices ... But this approach has proven transformative, both for people who hear voices and for ... is used around the world, but it still lags in the United States. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... Severna Park, Maryland (PRWEB) , ... May 31, ... ... the ability to attribute calls back to particular advertising campaigns, to monitor the ... teams so that they can maximize conversions and revenue. The software allows customers ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to ... a whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will ... the opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: